Dr. Kenneth Kenji Tanabe, MD

Dr. Tanabe practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Tanabe's NPI, 1164413613, was assigned on November 3, 2005. Dr. Tanabe graduated from UC San Diego School of Medicine in 1985. Dr. Tanabe holds Massachusetts license 78104.

Dr. Tanabe's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Tanabe's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Tanabe is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Tanabe to 5 more medical groups, 1 community health center and 1 home health agency, each named with a free account. Dr. Tanabe's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tanabe practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Tanabe's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Tanabe is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Tanabe's licenses on file in 5 states: Massachusetts, Maine, New Hampshire, Rhode Island and Texas.

CMS data shows 303 Medicare services from Dr. Tanabe across 11 procedure codes in 2024, for 164 Medicare patients. Medicare paid $41,948 for them.

CMS counts 164 Medicare patients who saw Dr. Tanabe in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tanabe's median patient age at 74, with 43% women.

In 2024, Dr. Tanabe wrote 31 Medicare Part D claims for 22 patients. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $37 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

Dr. Tanabe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tanabe as offering telehealth. CMS counts 83 procedures of melanoma (skin cancer) excision by Dr. Tanabe, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 326 papers to Dr. Tanabe, published from 2004 to 2024. 2019 was the busiest year, with 13. The most frequent topics are Kidney Transplantation, Liver Neoplasms and Carcinoma, Hepatocellular. Dr. Tanabe has published most often in Transplant Proc. Dr. Tanabe's most frequent co-authors are Michael Lanuti, MD, Derek Jesse Erstad, MD and Raymond T. Chung, MD.

Dmand AI links Dr. Tanabe to 2 clinical trials. Conditions studied include Carcinoma, Hepatocellular and Fibrosis.

CMS Open Payments shows 6 general payments to Dr. Tanabe from 5 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 46% of the total. GlaxoSmithKline, LLC. paid the most, $3,200.

Dmand AI lists 6 awards for Dr. Tanabe, most recently America's Top Doctors in 2014.

Dr. Tanabe graduated from UC San Diego School of Medicine in 1985. Dr. Tanabe is a member of ACS.

Dr. Tanabe is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.